The Impact of Multiple Malignancies on Patients with Bladder Carcinoma: A Population-Based Study Using the SEER Database

Table 3

Survival rates and Cox hazard ratios representing AB, BS, ABS, and BO cohorts, multivariate analysis.

		5-yr overall	10-yr overall	5-yr	10-yr	5-yr bladder	10-yr bladder
				CA specific	CA specific	CA specific	CA specific
AB (𝑛=17200)	HR	1.409	1.384	1.788	1.842	0.892	0.906
	95% CI	(1.375, 1.444)	(1.353, 1.416)	(1.733, 1.845)	(1.788, 1.898)	(0.852, 0.933)	(0.867, 0.947)
BS (𝑛=23739)	HR	0.824	0.936	1.191	1.522	0.446	0.488
	95% CI	(0.804, 0.845)	(0.917, 0.955)	(1.156, 1.228)	(1.484, 1.561)	(0.424, 0.468)	(0.467, 0.510)
ABS (𝑛=3141)	HR	1.163	1.255	1.882	2.209	0.485	0.517
	95% CI	(1.102, 1.227)	(1.198, 1.314)	(1.769, 2.002)	(2.093, 2.331)	(0.425, 0.552)	(0.458, 0.583)
BO (𝑛=118101)	HR	1.0	1.0	1.0	1.0	1.0	1.0

HRs reported with 95% confidence intervals (95% CI). All HRs calculated using BO cohort as the reference group. CA : cancer.